These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1707216

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 26. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 27. [A case report of prostate cancer resistant to endocrine therapy successfully treated with intra-arterial chemotherapy].
    Mima H, Asano M, Ozeki S, Ehara H, Takahashi Y, Ishihara S, Deguchi T, Kuriyama M, Ban Y, Kawada Y.
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1694-6. PubMed ID: 7574795
    [Abstract] [Full Text] [Related]

  • 28. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
    Yamauchi T, Okada K, Yoshida O.
    Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
    Uekado Y, Hirano A, Inagaki T, Hiroi A, Watanabe T.
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
    Umeki H, Yamaguchi Y, Tsugata M, Wakana K, Somekawa Y, Shimabukuro K, Ohara M, Terauchi T, Ichimura M, Otsuka I, Aso T.
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):377-82. PubMed ID: 12669397
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
    Page JP, Levi JA, Woods RL, Tattersall MN, Fox RM, Coates AS.
    Cancer Treat Rep; 1985 Jan; 69(1):105-7. PubMed ID: 3881176
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
    Dawson N, Figg WD, Brawley OW, Bergan R, Cooper MR, Senderowicz A, Headlee D, Steinberg SM, Sutherland M, Patronas N, Sausville E, Linehan WM, Reed E, Sartor O.
    Clin Cancer Res; 1998 Jan; 4(1):37-44. PubMed ID: 9516950
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 39. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P.
    Srp Arh Celok Lek; 1996 Dec; 124(11-12):292-6. PubMed ID: 9132962
    [Abstract] [Full Text] [Related]

  • 40. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Takahashi K, Sasaki Y, Ohkura H.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.